Navigation Links
Remicade Responders Maintain Improvement

Long term extension trials of ACT (Active Ulcerative Colitis 1 & 2) conducted in the United States and Europe show moderately to severely active ulcerative colitis (UC) patients who had responded to REMICADE (infliximab) in earlier trials maintained improvement in their clinical symptoms for up to two years.

The trials were conducted under co-principle investigators William Sandborn, M.D. of the Mayo Clinic and Walter Reinisch, M.D., of the University Hospital Vienna, Austria. The data measured by the Physician's Global Assessment (PGA), reveals that in patients who completed follow-up through week 56 of the extension trials, 92 percent reported mild or no disease activity; in patients followed through week 104, 97 percent reported mild or no disease activity.

At week 0 of the ACT extension trials, 76 percent of 229 responder patients enrolled had mild or no disease activity, as indicated by a PGA score of 0 or 1, and 41 percent had no disease activity (PGA score of 0). At week 56, 92 percent of those patients remaining in the extension trials (n=181) had mild or no disease activity, and 61 percent had no disease activity. At week 104, 97 percent of those patients remaining in the extension trials (n=97) had mild or no disease activity, and 75 percent had no disease activity.

"The data demonstrate the sustained efficacy of REMICADE for many patients with UC," said co-principle investigator Walter Reinisch, M.D., of the University Hospital Vienna, Austria. "Because UC is a chronic condition, many patients live with cycles of recurring flares. This can greatly hinder a person's social and professional life. The availability of therapies that quickly reduce symptoms and maintain response and remission long term is a significant benefit to patients."

Separate data also presented at DDW today show the significant impact of UC on patients' productivity, employment and social activities. A survey of 1,000 patients wh
'"/>




Page: 1 2 3

Related medicine news :

1. Remicade Emerges as a Treatment for Patients Suffering From Psoriasis Disorder
2. Remicade Therapy Effective in Treating Severe Psoriasis
3. Remicade(R) Get Approval for First and Only Biologic Treatment for Pediatric Crohns Disease
4. Responders On 9/11 Face Health Risks
5. More Money to Flow for First Responders at Ground Zero
6. Maintaining warmth during cold
7. Maintaining Weight Loss with Drugs
8. Maintaining a Pharma index could help track price fluctuations
9. Brain Plays Vital Role In Maintaining Bone Density
10. The Two-In-One Estrogen Therapy For Managing Menopause And Maintaining Healthy Skin
11. Beauty Queens Urge On The Importance Of Maintaining Bone Integrity
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Remicade Responders Maintain Improvement

(Date:8/28/2015)... ... ... The 6th Annual Survivor in the City, Chicago silent auction and ... to its cadre of widespread support—an official letter of support and gratitude from the ... community and the University of Illinois at Chicago’s Department of Neurosurgery, the Brain Aneurysm ...
(Date:8/28/2015)... ... August 28, 2015 , ... Saint ... grade protein with zero fat, carbs, sugar, gluten, lactose or caffeine in a ... for the 2015 SupplySide CPG Editor’s Choice Awards. , Five consumer packaged goods ...
(Date:8/28/2015)... Beach, FL. (PRWEB) , ... August 28, 2015 ... ... problems for businesses nationwide. Addictions specialist, Dr. James Strawbridge, gives a new approach ... believes that it should begin with the employer and employees getting together for ...
(Date:8/28/2015)... West Jordan, Utah (PRWEB) , ... August 28, ... ... has been awarded a three-year accreditation for its adolescent residential, counseling, day treatment ... Academy demonstrates that it meets international standards for quality and its pursuit of ...
(Date:8/28/2015)... ... August 28, 2015 , ... The Quatela Center for ... is the first and only nonsurgical product approved by the Food and Drug Administration ... Quatela and Dr. William Koenig are among the premier cosmetic surgeons ...
Breaking Medicine News(10 mins):Health News:Chicago Mayor Pens Official Support of Annual Survivor in the City Event Benefitting Brain Aneurysm Foundation 2Health News:Chicago Mayor Pens Official Support of Annual Survivor in the City Event Benefitting Brain Aneurysm Foundation 3Health News:Pocket Protein™ Named 2015 CPG Editor’s Choice Award Finalist by Informa’s SupplySide 2Health News:Pocket Protein™ Named 2015 CPG Editor’s Choice Award Finalist by Informa’s SupplySide 3Health News:West Ridge Academy Awarded CARF Three-Year Accrediation 2Health News:Non-surgical Treatment to Get Rid of The "Double Chin," Kybella™, Now Available at the Quatela Center for Plastic Surgery 2Health News:Non-surgical Treatment to Get Rid of The "Double Chin," Kybella™, Now Available at the Quatela Center for Plastic Surgery 3
... use of incense increases the risk of developing cancers of ... analysis, which the authors say is the first prospective investigation ... 2008 issue of CANCER, a peer-reviewed journal of ... of daily life in large parts of Asia. Researchers have ...
... Mich., Aug. 22 Stryker Corporation,(NYSE: SYK ) ... conferences:, September 3, 2008 - 9:45 a.m. ... Boston, Massachusetts, September 17, 2008 - 9:30 ... 2008 London, England, Simultaneous webcasts of the ...
... reduce unhealthy behaviors like binge drinking and eating junk ... But a new study in the Journal of Consumer ... to improve consumer health. , Authors Jonah Berger ... that linking a risky behavior with an "outgroup" (a ...
... hotel towels if they know other guests are doing ... Journal of Consumer Research examined participation rates in ... Authors Noah J. Goldstein (University of Chicago), Robert B. ... that the types of signs posted in hotel bathrooms ...
... Technology approved for control of food-borne pathogens in ... Robert Brackett, chief,science officer for the Grocery ... response to the U.S. Food & Drug,Administration (FDA) ... for,controlling food-borne pathogens in fresh iceberg lettuce and ...
... use eRx Network Medicare Part B transaction ... processing services in its stores nationwide, FORT WORTH, Texas, ... transaction services to the retail pharmacy,industry, announced today that it ... Part B claims, state,Medicaid DME claims and clinical administration programs ...
Cached Medicine News:Health News:Burning incense increases risk of respiratory tract cancers 2Health News:Stryker to Present at Investor Conferences 2Health News:Part of the in-group? A surprising new strategy helps reduce unhealthy behaviors 2Health News:A room with a viewpoint: conservation messages and motivation 2Health News:Grocery Manufacturers Association Strongly Supports U.S. Food & Drug Administration Decision on the Irradiation of Fresh Produce for Foodborne Pathogen Control 2Health News:eRx Network to Provide Transaction Processing and Revenue Cycle Management Services to Rite Aid 2
(Date:8/27/2015)... FRANKLIN, Mass. , Aug. 27, 2015 /PRNewswire/ ... in the KSSTA Knee Journal, compared the Arthrosurface ... "inlay" Arthroplasty design, versus an "onlay" design implant ... showed similar improvements in function and pain scores, ... showed progression of osteoarthritis (OA). However, 53% of ...
(Date:8/27/2015)... According to a new market research report ... Standing, Bariatric ), Material (Nylon, Padded, Canvas), Usage Type (Disposable, Reusable), ... MarketsandMarkets, the Medical Lifting Sling Market is poised to reach USD ... a CAGR of 11.4 % from 2015 to 2020. ... data T ables and 65 F ...
(Date:8/27/2015)... , Aug. 27, 2015   Proxsys ... Provider (IOPP™) is expanding its population health ... medication-focused transition of care program for hospitals ... Management," provides hospitals with technology systems and ... measures that have been mandated by Center ...
Breaking Medicine Technology:Study Demonstrates Dramatic Reduction in Progression of Osteoarthritis with the Arthrosurface "Inlay" Patellofemoral Implant Design Compared to Traditional "Onlay" Implant 2Study Demonstrates Dramatic Reduction in Progression of Osteoarthritis with the Arthrosurface "Inlay" Patellofemoral Implant Design Compared to Traditional "Onlay" Implant 3Medical Lifting Sling Market Worth USD 706.0 Million by 2020 2Medical Lifting Sling Market Worth USD 706.0 Million by 2020 3Medical Lifting Sling Market Worth USD 706.0 Million by 2020 4Rx Care Management by Proxsys Rx - Transition of Care Technology Helps Prevent Hospital Medication Errors 2
... Ontario, Dec. 12, 2011 Valeant Pharmaceuticals International, Inc. (NYSE: ... the Federal Trade Commission (FTC) voted unanimously to approve the ... dermatology unit of Sanofi (EURONEXT: SAN and NYSE: ... division of Janssen Pharmaceuticals, Inc. As a ...
... PharMEDium announced the first generation solution ... Operating Room (O.R.).  PharMEDium has developed the ... "Our certiMED™ system is designed to be ... Ready-to-Use O.R. syringe medications by providing a visual and ...
Cached Medicine Technology:Valeant Pharmaceuticals Receives Approval From FTC in Connection With Acquisition of Ortho Dermatologics and Dermik 2PharMEDium Adds O.R. Medication Verification System 2
... (5-Androstene-3-0L-17-one,Androstenolone, Dehydroisoandrosterone,Transdehydroandrosterone, DHEA) is a ... mostly in its,sulfate form (DHEA-S). ... based on the competition principle ... amount of DHEA-S present in ...
Beta-2 Microglobulin EIA Lipid / Protein Quantification 025-BC-1061...
Myoglobin EIA Lipid / Protein Quantification, Cardiovascular 024-IDC-13 Muscle Disease...
Human Growth Hormone EIA Endocrine Function 025-BC-1033...
Medicine Products: